Comparison of fludarabine/melphalan(flumel) with fludarabine/melphalan/bcnu or thiotepa(fbm/ftm) in patients with AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the ebmt alwp
Authors
Duque-Afonso, J.Finke, J.
Ngoya, M.
Labopin, M.
Nicholson, E.
Kottaridis, P.
Craddock, C.
Tholouli, E.
Protheroe, R.
Wagner-Drouet, E. M.
Bloor, Adrian
Valerius, T.
Wilson, K. M. O.
Savani, B. N.
Spyridonidis, A.
Nagler, A.
Mohty, M.
Affiliation
University of Freiburg/Klinik für Innere Medizin I, Freiburg, GermanyIssue Date
2022